Literature DB >> 10511240

Transplantation of neural progenitor and stem cells: developmental insights may suggest new therapies for spinal cord and other CNS dysfunction.

K I Park1, S Liu, J D Flax, S Nissim, P E Stieg, E Y Snyder.   

Abstract

Multipotent neural progenitors and stem cells may integrate appropriately into the developing and degenerating central nervous system. They may also be effective in the replacement of genes, cells, and nondiffusible factors in either a widespread or a more circumscribed manner, depending on the therapeutic demands of the clinical situation. In addition, they may be uniquely responsive to some types of neurodegenerative conditions. We believe that these various appealing capabilities are the normal expression of basic biologic properties and attributes of a stem cell. The therapeutic utility of some of those properties is illustrated in this review of ongoing work in our laboratory, particularly with regard to spinal dysfunction. In these examples, we believe we have tapped into a mechanism that underlies a remarkable degree of natural plasticity programmed into the nervous system at the cellular level, and we have now exploited those properties for therapeutic ends.

Entities:  

Mesh:

Year:  1999        PMID: 10511240     DOI: 10.1089/neu.1999.16.675

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  16 in total

Review 1.  Stem cells: cross-talk and developmental programs.

Authors:  Jaime Imitola; Kook In Park; Yang D Teng; Sahar Nisim; Mahesh Lachyankar; Jitka Ourednik; Franz-Josef Mueller; Rene Yiou; Anthony Atala; Richard L Sidman; Mark Tuszynski; Samia J Khoury; Evan Y Snyder
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-05-29       Impact factor: 6.237

2.  Stress-resistant neural stem cells positively influence regional energy metabolism after spinal cord injury in mice.

Authors:  Karsten Schwerdtfeger; Angelika E M Mautes; Christian Bernreuther; Yifang Cui; Jérôme Manville; Marcel Dihné; Simon Blank; Melitta Schachner
Journal:  J Mol Neurosci       Date:  2011-08-11       Impact factor: 3.444

Review 3.  Prospects for neural stem cell-based therapies for neurological diseases.

Authors:  Jaime Imitola
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

4.  Neural stem cell migration toward gliomas in vitro.

Authors:  Oliver Heese; Andreas Disko; Dorothea Zirkel; Manfred Westphal; Katrin Lamszus
Journal:  Neuro Oncol       Date:  2005-10       Impact factor: 12.300

Review 5.  Pharmacological treatment of traumatic brain injury: a review of agents in development.

Authors:  J Hatton
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

6.  Bioprinting of stem cell expansion lattices.

Authors:  Christopher D Lindsay; Julien G Roth; Bauer L LeSavage; Sarah C Heilshorn
Journal:  Acta Biomater       Date:  2019-05-13       Impact factor: 8.947

7.  Neuronal and glial differentiation following culture of the human embryonic cortical stem cells.

Authors:  Peng Liang; Shiguang Zhao; Keiji Kawamoto; Lianhong Jin; Enzhong Liu
Journal:  Hum Cell       Date:  2003-09       Impact factor: 4.174

8.  Regional energy metabolism following short-term neural stem cell transplantation into the injured spinal cord.

Authors:  Angelika E M Mautes; Jiankun Liu; Jörg Brandewiede; Jérôme Manville; Evan Snyder; Melitta Schachner
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Efficacy of Human Adipose Tissue-Derived Stem Cells on Neonatal Bilirubin Encephalopathy in Rats.

Authors:  Naser Amini; Nasim Vousooghi; Mahmoudreza Hadjighassem; Mehrdad Bakhtiyari; Neda Mousavi; Hosein Safakheil; Leila Jafari; Arash Sarveazad; Abazar Yari; Sara Ramezani; Faezeh Faghihi; Mohammad Taghi Joghataei
Journal:  Neurotox Res       Date:  2016-01-27       Impact factor: 3.911

10.  Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease.

Authors:  Kimberly B Bjugstad; Yang D Teng; D Eugene Redmond; John D Elsworth; Robert H Roth; Shannon K Cornelius; Evan Y Snyder; John R Sladek
Journal:  Exp Neurol       Date:  2008-02-14       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.